Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care
- PMID: 20636166
- PMCID: PMC3120058
- DOI: 10.1089/jpm.2010.9808
Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care
Abstract
Depression is prevalent and undertreated in patients receiving hospice care. Standard antidepressants do not work rapidly or often enough to benefit most of these patients. Here, two cases are reported in which a single oral dose of ketamine provided rapid and moderately sustained symptom relief for both depression and anxiety. In addition, no adverse effects were noted. Further investigation with randomized, controlled clinical trials is necessary to firmly establish the effectiveness of oral ketamine for the treatment of depression and anxiety in patients receiving hospice care. Ketamine may be a promising safe, effective, and cost-effective rapid treatment for depression and anxiety in this population.
Figures


Similar articles
-
Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.J Palliat Med. 2013 Aug;16(8):958-65. doi: 10.1089/jpm.2012.0617. Epub 2013 Jun 27. J Palliat Med. 2013. PMID: 23805864 Free PMC article. Clinical Trial.
-
Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases.Psychosomatics. 2015 Jul-Aug;56(4):329-37. doi: 10.1016/j.psym.2014.05.005. Epub 2014 Jun 5. Psychosomatics. 2015. PMID: 25616995 Free PMC article.
-
Compounded oral ketamine.Int J Pharm Compd. 2012 Sep-Oct;16(5):364-8. Int J Pharm Compd. 2012. PMID: 23072195
-
[Ketamine for treatment of acute depression].Ugeskr Laeger. 2013 Sep 9;175(37):2090-3. Ugeskr Laeger. 2013. PMID: 24011203 Review. Danish.
-
Ketamine and depression: a narrative review.Drug Des Devel Ther. 2019 Aug 27;13:3051-3067. doi: 10.2147/DDDT.S221437. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31695324 Free PMC article. Review.
Cited by
-
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.Curr Neuropharmacol. 2017;15(1):57-70. doi: 10.2174/1570159x14666160321123221. Curr Neuropharmacol. 2017. PMID: 26997505 Free PMC article. Review.
-
Novel Glutamatergic Treatments for Severe Mood Disorders.Curr Behav Neurosci Rep. 2015 Dec;2(4):198-208. doi: 10.1007/s40473-015-0050-5. Epub 2015 Oct 9. Curr Behav Neurosci Rep. 2015. PMID: 26824031 Free PMC article.
-
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials.Pharmacol Rep. 2020 Jun;72(3):543-562. doi: 10.1007/s43440-020-00097-z. Epub 2020 Apr 16. Pharmacol Rep. 2020. PMID: 32301056 Free PMC article.
-
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series.J Clin Psychopharmacol. 2017 Aug;37(4):464-467. doi: 10.1097/JCP.0000000000000717. J Clin Psychopharmacol. 2017. PMID: 28514237 Free PMC article.
-
Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial.Eur Arch Psychiatry Clin Neurosci. 2016 Dec;266(8):695-702. doi: 10.1007/s00406-016-0685-6. Epub 2016 Mar 16. Eur Arch Psychiatry Clin Neurosci. 2016. PMID: 26984349 Clinical Trial.
References
-
- Wilson KG. Chochinov HM. de Faye BJ. Breitbart W. Diagnosis, management of depression in palliative care. In: Chochinov HM, editor; Breitbart W, editor. Handbook of Psychiatry in Palliative Medicine. New York: Oxford University Press; 2000. pp. 25–50.
-
- National Institutes of Health. National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15–17, 2002. J Natl Cancer Inst Monographs. 2004;2004:9–16. - PubMed
-
- Wilson KG. Chochinov HM. Skirko MG. Allard P. Chary S. Gagnon PR. Macmillan K. De Luca M. O'Shea F. Kuhl D. Fainsinger RL. Clinch JJ. Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage. 2007;33:118–129. - PubMed
-
- Goldberg RJ. Mor V. A survey of psychotropic use in terminal cancer patients. Psychosomatics. 1985;26:745–748, 751. - PubMed
-
- McDaniel JS. Brown FW. Cole SA. Assessment of depression, grief reactions in the medically ill. In: Stoudemire A, editor; Fogel BS, editor; Greenberg DB, editor. Psychiatric Care of the Medical Patient. New York: Oxford University Press; 2000. pp. 149–164.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical